Accès rapides :

Vous êtes ici :

  1. Accueil
  2. Publications et outils
  3. Bases de données
  4. Fiches toxicologiques
  5. Acrylamide (FT 119) (rubrique sélectionnée)

Acrylamide

Fiche toxicologique n° 119

Sommaire de la fiche

Édition : Septembre 2021

Bibliographie

  1. Acrylamide. Registration dossier, ECHA, 2018 (https://echa.europa.eu/fr/home).
  2. Acrylamide - In: Base de données HSDB. Hamilton: Centre canadien d'Hygiène et de Sécurité; 2007 (https://toxnet.nlm.nih.gov/).
  3. Acrylamide. In : The Merck index. An encyclopedia of chemicals, drugs, and biologicals. 14th edition. Whitehouse Station : Merck and Co ; 2006.
  4. Acrylamide M-3. In: MétroPol. INRS, 2015 (https://www.inrs.fr/metropol/).
  5. Mise en œuvre de la réglementation relative aux atmosphères explosives (ATEX) – Guide méthodologique. Brochure ED 945. INRS, août 2011 (https://www.inrs.fr/).
  6. Acrylamide. Toxicological profiles. ATSDR, 2012 (https://www.atsdr.cdc.gov/).
  7. Acrylamide. European risk assessment report, ECHA, 2002 (https://echa.europa.eu/fr/home).
  8. Doerge DR, Young JF, McDaniel LP, Twaddle NC et al. – Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice.Toxicol Appl Pharmacol. 2005 ; 202 : 258-267.
  9. Doerge DR, Young JF, McDaniel LP, Twaddle NC et al. – Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats.Toxicol Appl Pharmacol. 2005b ; 208 : 199-209.
  10. Sumner SCJ, Williams CC, Snyder RW, Krol WL et al. – Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral or inhalation exposure. Toxicol Sci. 2003 ; 75 : 260-270.
  11. Shipp A, Lawrence G, Gentry R, McDonald T et al. – Acrylamide: a review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol. 2006 ; 36 : 481-608.
  12. Toxicology and carcinogenesis studies of acrylamide (CAS No. 79-06-1) in rats F344/N rats and B6C3F1 mice (feed and drinking water studies). NTP Technical report series TR-575. US Department of Health and Human Services, 2012.
  13. Bergmark E, Calleman CJ et Costa LG – Formation of hemoglobin adducts of acrylamide and its epoxyde metabolite glycidamide in the rat. Toxicol Appl Pharmacol. 1991 ; 111 : 352-363.
  14. Evaluation des indicateurs biologiques d’exposition et recommandation de valeurs biologiques de référence pour l’acrylamide – Avis de l’ANSES, Rapport d’expertise collective, 2017 (https://www.anses.fr/fr).
  15. Fennel TR, Sumner SCJ, Snyder RW, Burgess J et al. – Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci. 2005 ; 85 : 447-459.
  16. Fennel TR, Sumner SCJ, Snyder RW, Burgess J et al. – Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol Sci. 2006 ; 93(2) : 256-267.
  17. He F, Zhang S, Wang H, Li G, Zhang Z, Li F, et al. Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand J Work Env Hea.1989; 15: 125-129.
  18. Fuhr U et al. Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev. 2006; 15(2):266-71.
  19. Acrylamide. In : Demeter. Documents pour l'évaluation médicale des produits toxiques vis à vis de la reproduction DEM 001 Mars 2018 (https://www.inrs.fr/demeter).
  20. Valeurs limites d’exposition en milieu professionnel, L’acrylamide. Avis de l’Anses : Rapport d’expertise collective, Novembre 2011 (https://www.anses.fr/fr).
  21. Acrylamide. Expertise en vue de la fixation de valeurs limites à des agents chimiques en milieu professionnel. Procès-verbal du CES VLEP de la réunion du 4 avril 2013. Maisons-Alfort : ANSES ; 2013 (https://www.anses.fr/fr/system/files/VLEP-Pv-2013-04-04.pdf ).
  22. Deutsche Forschungsgemeinshaft. List of MAK and BAT values 2016. Wiley-VCH Verlag, 2015 (http://www.dfg.de/en/dfg_profile/statutory_bodies/senate/health_hazards/index.html).
  23. Bull PJ et al. - An occupational hygiene investigation of exposure to acrylamide and the role for urinary S-carboxyethyl-cysteine (CEC) as a biological marker. Ann. Occup. Hyg ., 2005 ; 49 (8) : 683-690.
  24. Hagmar L et al. - Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of exposure. Scand. J. Work Environ. Health , 2001 ; 27 (4) : 219-226.
  25. C. Sams et al. Towards a biological monitoring guidance value for acrylamide. Toxicology Letters, 2015, 19;237 (1) : 30-37.
  26. Acrylamide. In: Gestis-database on hazardous substances. IFA (https://www.dguv.de/ifa/gestis/gestis-stoffdatenbank/index-2.jsp).
  27. Friedman MA, Dulak LH et Stedhma MA – A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol. 1995 ; 27(1):95-105.
  28. Fang J, Liang CL, Jia XD et Li N – Immunotoxicity of acrylamide in female BALB/c mice. Biomed Environ Sci. 2014 ; 27(6) : 401-409.
  29. Yener Y, Sur E, Telatar T et Oznurlu Y – The effect of acrylamide on alpha-naphthyl acetate esterase enzyme in blood circulating lymphocytes and gut associated lymphoid tissues in rats. Exp Toxicol Pathol. 2013 ; 65 : 143-146.
  30. Zamani E, Shorkrzadeh M, Ziar A, Adedian-Kenari S et al. – Acrylamide attenuated immune tissues functions via induction of apoptosis and oxidative stress: protection by L-carnitine. Human Exp Toxicol. 2018 ; 37(8) : 859-869.
  31. Gedik S, erdemli ME, Gul M, Yigitcan B et al. – Hepatoprotective effects of crocin on biochemical and histopathological alterations following acrylamide-induced liver injury in Wistar rats. Biome Pharmacother. 2017 ; 95 ; 764-770.
  32. Acrylamide. In: Some industrial chemicals. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 60. IARC, 1994.
  33. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA et al. – Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol. 1986 ; 85 : 154-168.
  34. Bull RJ, Robinson M, Laurie RD, Stoner GD et al. – Carcinogenic effects of acrylamide in SENCAE and A/J mice. Cancer Res. 1984 ; 44 : 107-111.
  35. Bull RJ, Robinson M et Stober JA – Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett. 1984b ; 24 : 209-212.
  36. Wang H, Huang P, Lie T, Li J et al. – Reproductive toxicity of acrylamide-treated male rats. Repro Toxicol. 2010 ; 29 : 225-230.
  37. Takami S, Imai T, Cho Y6M, Ogawa K et al. – Juvenile rats do not exhibit elevated sensitivity to acrylamide toxicity after oral administration for 12 weeks. J Appl Toxicol. 2012 ; 32 : 959-967.
  38. Aras D, Cakar Z, Ozkavukcu S, Can A et al. – In vivo acrylamide exposure may cause severe toxicity to mouse oocytes through its metabolite glycidamide. PLoS One. 2017 ; 12(2).
  39. Duan X, Wang QC, Chen KL, Zhu CC et al. – Acrylamide toxic effects on mouse oocyte quality and fertility in vivo. Sci Rep. 2015 ; 5 : 11562.
  40. Wei Q, Li J, Li X, Zhang L et al. – Reproductive toxicity in acrylamide-treated female mice. Repro Toxicol. 2014 ; 46 : 121-128.
  41. Takahashi M, Shibutani M, Nakahigashi J, Sakaguchi N et al. – Limited lactation transfer of acrylamide to rat offspring on maternal oral administration during gestation and lactation periods. Arch Toxicol. 2009 ; 83 : 785-793.
  42. Field EA, Price CJ, Sleet RB; Melissa C et al. – Developmental toxicity evaluation of acrylamide in rats and mice. Fundam Appl Toxicol. 1990 ; 14(3) : 502-512.
  43. Hulas-Stasiak M, Dobrowolski P, Tomaszewska E et Kostro K – Maternal acrylamide treatment reduces ovarian follicle number in newborn guinea-pig offspring. Reprod Toxicol. 2013 ; 42 : 125-131.
  44. Garey J et Paule MG – Effects of chronic low-dose acrylamide exposure on progressive ratio performance in adolescent rats. Neurotoxicology. 2007 ; 28(5) : 998-1002.
  45. Garey J et Paule MG – Effects of chronic oral acrylamide exposure on incremental repeated acquisition (learning) task performance in Fischer 344 rats. Neurotoxicol Teratol. 2010 ; 32 : 220-225.
  46. Wise LD, Gordon LR, Soper KA, Duchai DM et al. – Developmental neurotoxicity evaluation of acrylamide in Sprague-Dawley rats. Neurotoxicol Teratol. 1995 ; 17(2) : 189-198.
  47. Tyl RW, Friedman MA, Losco PA, Fisher LC et al. – Rat two-generation reproduction and dominant lethal study of acrylamide in drinking water. Repro Toxicol. 2000 ; 14 : 385-401.
  48. Husan R, Dixit R, Das M et Seth PK – Neurotoxicity of acrylamide in developing rat brain: Changes in the levels of brain biogenic amines and activities of monoamine oxidase and acetylcholine esterase. Ind Health. 1987 ; 25(1) : 19-28.
  49. Acrylamide. NICNAS, Priority existing chemical assessment report. Vol. 23 ; 2002 ; 174 p.
  50. Lambert J, Matthieu L, Dockx P. - Contact dermatitis from acrylamide. Contact Dermatitis, 1988 ; 19 : 65.
  51. Dooms-Goossens A, Garmyn M, Degreef H. - Contact allergy to acrylamide. Contact Dermatitis, 1991 ; 24 : 71.
  52. Beyer JD, Belsito DV. – Allergic contact dermatitis from acrylamide in a chemical mixer. Contact Dermatitis, 2000 ; 42 : 181.
  53. Aalto-Korte K et al. - Biochemist's occupational allergic contact dermatitis from iodoacetamide and acrylamide. Contact Dermatitis, 2002 ; 47 : 361-364.
  54. Hagmar L et al. - Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of exposure. Scand. J. Work Environ. Health, 2001 ; 27 (4) : 219-226.
  55. Kjuus H, Goffeng LO, Heier MS et al. - Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand. J. Work Environ. Health, 2004 ; 30 (1) : 21-29.
  56. Goffeng LO, Heier MS, Kjuus H et al. – Nerve conduction, visual evoked responses and electroretinography in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents. Neurotoxicol. Teratol., 2008 ; 30(3) : 186-194.
  57. Goffeng LO, Kjuus H, Heier MS et al. – Colour vision and light sensitivity in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents. Neurotoxicology, 2008 ; 29(1) : 31-39.
  58. Goffeng LO, Alverstrand M, Ulvestad B et al. – self-reported symptoms and neuropsychological function among tunnel workers previously exposed to acrylamide and N-methylolacrylamide. Scand. J. Work Environ. Health, 2011 ; 37(2) : 136-146.
  59. Hogervorst JG, Fortner RT, Mucci LA et al. – Associations between dietary acrylamide intake and plasma sex hormone levels. Cancer Epidemiol Biomarkers Prev, 2013 ; 22(11) : 1-22.
  60. Nagata C, Konishi K, Tamura T et al. – Associations of acrylamidee intake with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Epidemiol Biomarkers Prev, 2015 ; 24(1) : 249-254.
  61. Acrylamide. Health and Safety Guide. IPCS ; 1991 ; n° 45 (http://www.inchem.org/pages/about.html).
  62. Kjuus H, Hansteen IL, Ryberg D et al. – Chromosome aberrations in tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand. J. Work Environ. Health, 2005 ; 31 (4) : 300-306.
  63. Garnier R. Acrylamide. EMC – Pathologie professionnelle et de l’environnement. 2018 ; 13(1) : 1-10 [Article 16-541-B-20].
  64. Sobel W, Bond GG, Parsons TW et al. - Acrylamide cohort mortality study. Br. J. Ind. Med., 1986 ; 43(11) : 785-788.
  65. Swaen GMH, Haidar S, Burns CJ et al. - Mortality study update of acrylamide workers. Occup. Env Med., 2007 ; 64(6) : 396-401.
  66. Marsh GM, Lucas LJ, Youk AO, Shall LC - Mortality patterns among workers exposed to acrylamide, 1994 follow up. Occup. Env. Med., 1999 ; 56 : 181-180.
  67. Marsh GM, Youk AO, Buchanich JM et al. - Mortality patterns among workers exposed to acrylamide : updated follow up. J. Occup. Environ. Med, 2007 ; 49 : 82-95.
  68. Pelucchi C, La Vecchia C, Bosetti C et al. – Exposure to acrylamide and human cancer – A review and meta-analysis of epidemiological studies. Ann. Oncol., 2011 ; 22(7) : 1487-1499.
  69. Pelucchi C, Bosetti C, Galeone C, La Vecchia C – Dietary acrylamide and cancer risk : – An update meta-analysis. Int. J. Cancer, 2015 ; 136(12) : 2912-2922.
  70. Pedersen M, von Stedingk H, Botsivali M et al. – Birth weight, head circumference, and prenatal exposure to acrylamide from maternal diet: the European prospective mother-child study (NewGeneris). Environ. Health Perspect., 2012 ; 120(12) : 1739-1745.
  71. Duarte-Salles T, von Stedingk H, Granum B et al. – Dietary acrylamide intake during pregnancy and fetal growth – Results from the Norwegian mother and child cohort study (MoBa). Environ. Health Perspect., 2013 ; 121(3) : 374-379.
  72. Kadawathagedara M, Chan Hon Tong A, Heude B et al. – Dietary acrylamide intake during pregnancy and anthropometry at birth in the French EDEN mother-child cohort study. Environ. Res., 2016 ; 149 : 189-196.
  73. Kadawathagedara M, Botton J, de Lauzon-Guillain B et al. – Dietary acrylamide intake during pregnancy and postnatal growth and obesity: results from the norwegian mother and child cohort study (MoBa). Environ. Int., 2018 ; 113 : 325-334.
  74. Principes généraux de ventilation. Guide pratique de ventilation ED 695. INRS (https://www.inrs.fr/).
  75. Electricité statique. Brochure ED 874. INRS (https://www.inrs.fr/).
  76. Le permis de feu. Brochure ED 6030. INRS (https://www.inrs.fr/).
  77. Signalisation de santé et de sécurité au travail - Réglementation. Brochure ED 6293. INRS (https://www.inrs.fr/).
  78. Cuves et réservoirs. Interventions à l'extérieur ou à l'intérieur des équipements fixes utilisés pour contenir ou véhiculer des produits gazeux, liquides ou solides. Recommandation CNAM R 435. Assurance Maladie, 2008 (https://www.ameli.fr/entreprise/tableau_recommandations).
  79. Vêtements de travail et équipements de protection individuelle – Propriétés antistatiques et critère d’acceptabilité en zone ATEX. Note documentaire ND 2358. INRS (https://www.inrs.fr/).
  80. EPI et vêtements de travail : mieux comprendre leurs caractéristiques antistatiques pour prévenir les risques d'explosion. Notes techniques NT33. INRS (https://www.inrs.fr/). 
  81. Risques chimiques ou biologiques. Retirer sa tenue de protection en toute sécurité. Cas n°1 : Décontamination sous la douche. Dépliant ED 6165. INRS (https://www.inrs.fr/).
  82. Risques chimiques ou biologiques. Retirer sa tenue de protection en toute sécurité. Cas n°3 : Sans décontamination de la tenue. Dépliant ED 6167. INRS (https://www.inrs.fr/).
  83. Risques chimiques ou biologiques. Retirer ses gants en toute sécurité. Gants à usage unique. Dépliant ED 6168. INRS (https://www.inrs.fr/)
  84. Risques chimiques ou biologiques. Retirer ses gants en toute sécurité. Gants réutilisables. Dépliant ED 6169. INRS (http://www.inrs.fr).
  85. Les appareils de protection respiratoire - Choix et utilisation. Brochure ED 6106. INRS (https://www.inrs.fr/).
  86. Forsberg K, Den Borre AV, Henry III N, Zeigler JP – Quick selection guide to chemical protective clothing. 6th ed. Hoboken : John Wiley & Sons ; 260 p.
  87. Quels vêtements de protection contre les risques chimiques. Fiche pratique de sécurité ED 127. INRS (https://www.inrs.fr/).
  88. Les équipements de protection individuelle des yeux et du visage - Choix et utilisation. Brochure ED 798. INRS (https://www.inrs.fr/).
EN SAVOIR PLUS SUR LES FICHES TOXICOLOGIQUES